CarsonAllaria Wealth Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $755 | Hold |
160
| – | – | ﹤0.01% | 342 |
|
|
2025
Q1 | $734 | Hold |
160
| – | – | ﹤0.01% | 352 |
|
|
2024
Q4 | $766 | Hold |
160
| – | – | ﹤0.01% | 333 |
|
|
2024
Q3 | $750 | Hold |
160
| – | – | ﹤0.01% | 371 |
|
|
2024
Q2 | $904 | Hold |
160
| – | – | ﹤0.01% | 352 |
|
|
2024
Q1 | $658 | Hold |
160
| – | – | ﹤0.01% | 375 |
|
|
2023
Q4 | $675 | Hold |
160
| – | – | ﹤0.01% | 339 |
|
|
2023
Q3 | $691 | Hold |
160
| – | – | ﹤0.01% | 344 |
|
|
2023
Q2 | $1.05K | Hold |
160
| – | – | ﹤0.01% | 351 |
|
|
2023
Q1 | $1.09K | Hold |
160
| – | – | ﹤0.01% | 331 |
|
|
2022
Q4 | $1K | Hold |
160
| – | – | ﹤0.01% | 333 |
|
|
2022
Q3 | $2K | Hold |
160
| – | – | ﹤0.01% | 288 |
|
|
2022
Q2 | $2K | Hold |
160
| – | – | ﹤0.01% | 288 |
|
|
2022
Q1 | $2K | Hold |
160
| – | – | ﹤0.01% | 308 |
|
|
2021
Q4 | $3K | Buy |
+160
| New | +$3K | ﹤0.01% | 307 |
|